Published in Antimicrob Agents Chemother on September 04, 2007
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med (2002) 17.04
Invasive aspergillosis. Clin Infect Dis (1998) 9.72
Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase. Antimicrob Agents Chemother (1994) 6.45
Echinocandin antifungal drugs. Lancet (2003) 5.92
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J Clin Microbiol (2004) 4.70
Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev (2001) 4.49
750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem (1995) 3.61
In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob Agents Chemother (2001) 3.28
In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole. J Clin Microbiol (1999) 2.82
Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity. J Infect Dis (2004) 2.81
Systemic fungal infections caused by Aspergillus species: epidemiology, infection process and virulence determinants. Curr Drug Targets (2005) 2.60
Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob Agents Chemother (2004) 2.28
Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus. Antimicrob Agents Chemother (2003) 2.27
Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin. Antimicrob Agents Chemother (2006) 2.19
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol (2005) 1.87
Attenuation of the activity of caspofungin at high concentrations against candida albicans: possible role of cell wall integrity and calcineurin pathways. Antimicrob Agents Chemother (2005) 1.75
Menacing mold: the molecular biology of Aspergillus fumigatus. Annu Rev Microbiol (2002) 1.69
Characterization of Aspergillus nidulans mutants deficient in cell wall chitin or glucan. J Bacteriol (1992) 1.54
In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points. Antimicrob Agents Chemother (2003) 1.17
Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis. J Antimicrob Chemother (2006) 1.12
Transient Accumulation of Glycine Betaine and Dynamics of Endogenous Osmolytes in Salt-Stressed Cultures of Sinorhizobium meliloti. Appl Environ Microbiol (1997) 1.11
Choline Derivatives Involved in Osmotolerance of Penicillium fellutanum. Appl Environ Microbiol (1998) 0.99
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome. Clin Infect Dis (2005) 0.97
Interrelations between glycine betaine catabolism and methionine biosynthesis in Sinorhizobium meliloti strain 102F34. J Bacteriol (2006) 0.97
Glycine betaine: reserve form of choline in Penicillium fellutanum in low-sulfate medium. Appl Environ Microbiol (1999) 0.92
Modification of rapid susceptibility assay for antifungal susceptibility testing of Aspergillus fumigatus. J Clin Microbiol (2003) 0.89
Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp. Antimicrob Agents Chemother (2003) 0.88
New methods to assess susceptibilities of Aspergillus isolates to caspofungin. J Clin Microbiol (2003) 0.84
A nuclear-magnetic-resonance-based assay for betaine-homocysteine methyltransferase activity. Anal Biochem (2004) 0.80
Invasive pulmonary aspergillosis. Expert Rev Anti Infect Ther (2005) 0.79
Antifungal effects on metabolite profiles of medically important yeast species measured by nuclear magnetic resonance spectroscopy. Antimicrob Agents Chemother (2006) 0.79
Cytological effects of fungal metabolites produced by fungi isolated from Egyptian poultry feedstuffs. J Basic Microbiol (1989) 0.79
Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann Intern Med (1982) 3.45
Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol (2001) 3.02
Whither health care in South Africa? BMJ (1993) 2.68
Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis (1995) 2.59
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database Syst Rev (2006) 2.13
Human erythrocyte metabolism studies by 1H spin echo NMR. FEBS Lett (1977) 1.98
Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin). Lancet (1971) 1.93
Application of spin-echo nuclear magnetic resonance to whole-cell systems. Membrane transport. Biochem J (1979) 1.73
Phospholipase activity in Cryptococcus neoformans: a new virulence factor? J Infect Dis (1997) 1.72
A prospective study of adverse reactions associated with vancomycin therapy. J Antimicrob Chemother (1985) 1.64
Is semiquantitative culture of central vein catheter tips useful in the diagnosis of catheter-associated bacteremia? J Clin Microbiol (1986) 1.60
Campylobacter jejuni: incidence in processed broilers and biotype distribution in human and broiler isolates. Appl Environ Microbiol (1982) 1.56
Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans. Infect Immun (1997) 1.45
Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro. Clin Exp Immunol (1975) 1.40
Campylobacter jejuni in broilers: the role of vertical transmission. J Hyg (Lond) (1986) 1.38
Cryptococcosis: clinical and biological aspects. Med Mycol (2000) 1.35
Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: equations and parameter refinement. Biochem J (1999) 1.34
Molecular weights of the Thy-1 glycoproteins from rat thymus and brain in the presence and absence of deoxycholate. Biochem J (1978) 1.33
Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: computer simulation and metabolic control analysis. Biochem J (1999) 1.31
Disseminated candidiasis: evidence of a distinctive syndrome in heroin abusers. Br Med J (Clin Res Ed) (1983) 1.31
Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management. Clin Microbiol Infect (2009) 1.28
Proton NMR spectroscopic studies of dipeptidase in human erythrocytes. Biochem Biophys Res Commun (1983) 1.25
Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. Clin Microbiol Infect (2009) 1.24
Cryptococcus neoformans var. gattii infection in northern Australia: existence of an environmental source other than known host eucalypts. Trans R Soc Trop Med Hyg (1998) 1.23
Candidemia following solid organ transplantation in the era of antifungal prophylaxis: the Australian experience. Transpl Infect Dis (2009) 1.22
Purification and characterization of secretory phospholipase B, lysophospholipase and lysophospholipase/transacylase from a virulent strain of the pathogenic fungus Cryptococcus neoformans. Biochem J (2000) 1.19
Assimilation of alpha-glutamyl-peptides by human erythrocytes. A possible means of glutamate supply for glutathione synthesis. Biochem J (1985) 1.19
Susceptibility of Campylobacter jejuni to twenty-three antimicrobial agents. Pathology (1983) 1.18
Identification of pathogenic yeasts of the imperfect genus Candida by polymerase chain reaction fingerprinting. Electrophoresis (1997) 1.17
Active site directed effectors of allosteric enzymes. Biochim Biophys Acta (1975) 1.17
Characterization of Cryptococcus neoformans by random DNA amplification. Lett Appl Microbiol (1996) 1.15
Pathways of glutamine metabolism in Spodoptera frugiperda (Sf9) insect cells: evidence for the presence of the nitrogen assimilation system, and a metabolic switch by 1H/15N NMR. J Biotechnol (2000) 1.15
Isolation of two molecular types of Cryptococcus neoformans var. gattii from insect frass. Med Mycol (2003) 1.14
Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans variety gattii. Clin Infect Dis (1992) 1.13
Patterns of growth and body condition in sea otters from the Aleutian archipelago before and after the recent population decline. J Anim Ecol (2006) 1.12
Comparison of use of phenotypic and genotypic characteristics for identification of species of the anamorph genus Candida and related teleomorph yeast species. J Clin Microbiol (1997) 1.12
HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids. Immunology (1992) 1.12
Horizontal transmission of Campylobacter jejuni amongst broiler chicks: experimental studies. Epidemiol Infect (1990) 1.10
A Case of Aneurysm of the Abdominal Aorta treated by the Introduction of Silver Wire; with a Description of Instruments invented and constructed by Mr. G. H. Colt to facilitate the introduction of Wire into Aneurysms. Med Chir Trans (1903) 1.09
Cell volume dependence of 1H spin-echo NMR signals in human erythrocyte suspensions. The influence of in situ field gradients. Biochim Biophys Acta (1984) 1.09
Equilibrium binding of coenzymes and substrates to nicotinamide-adenine dinucleotide phosphate-linked isocitrate dehydrogenase from bovine heart mitochondria. Biochem J (1978) 1.08
The behaviour of coupled enzyme systems in the transient and steady-state regions of the reaction. Biochim Biophys Acta (1974) 1.08
Conformation of reduced glutathione in aqueous solution by 1H and 13C n.m.r. Int J Pept Protein Res (1987) 1.08
Heteronuclear NMR studies of metabolites produced by Cryptococcus neoformans in culture media: identification of possible virulence factors. Magn Reson Med (1999) 1.08
Regulation of the human-erythrocyte hexose-monophosphate shunt under conditions of oxidative stress. A study using NMR spectroscopy, a kinetic isotope effect, a reconstituted system and computer simulation. Eur J Biochem (1985) 1.07
In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (1983) 1.06
Measuring protein self-association using pulsed-field-gradient NMR spectroscopy: application to myosin light chain 2. J Biomol NMR (1995) 1.06
Mechanism of nonspecific macrophage-mediated cytotoxicity: evidence for lack of dependence upon oxygen. J Immunol (1978) 1.05
Biochemical and functional characterisation of secreted phospholipase activities from Cryptococcus neoformans in their naturally occurring state. J Med Microbiol (1999) 1.04
Cryptococcomas distinguished from gliomas with MR spectroscopy: an experimental rat and cell culture study. Radiology (2001) 1.02
Cellulitis due to Pseudomonas putrefaciens: possible production of exotoxins. Rev Infect Dis (1991) 1.02
Identification by random amplification of polymorphic DNA of a common molecular type of Cryptococcus neoformans var. neoformans in patients with AIDS or other immunosuppressive conditions. J Infect Dis (1996) 1.02
Skull-base osteomyelitis: fungal vs. bacterial infection. Clin Microbiol Infect (2011) 1.02
Defensin-like peptide-2 from platypus venom: member of a class of peptides with a distinct structural fold. Biochem J (2000) 1.02
A proton n.m.r. study of iminodipeptide transport and hydrolysis in the human erythrocyte. Possible physiological roles for the coupled system. Biochem J (1984) 1.02
Systemic sepsis and intravenous devices. A prospective survey. Med J Aust (1984) 1.01
Clinician response to Candida organisms in the urine of patients attending hospital. Eur J Clin Microbiol Infect Dis (2007) 1.01
Endogenous phospholipase and choline release in human erythrocytes: a study using 1H-NMR spectroscopy. Biochem Biophys Res Commun (1982) 0.99
Comparison of computer simulations of the F-type and L-type non-oxidative hexose monophosphate shunts with 31P-NMR experimental data from human erythrocytes. Eur J Biochem (1989) 0.99
NMR spin exchange kinetics at equilibrium in membrane transport and enzyme systems. J Theor Biol (1983) 0.99
Intracellular pH in stored erythrocytes. Refinement and further characterisation of the 31P-NMR methylphosphonate procedure. Biochim Biophys Acta (1986) 0.98
Nuclear magnetic resonance characterization of the Jun leucine zipper domain: unusual properties of coiled-coil interfacial polar residues. Biochemistry (1995) 0.98
Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP). Am J Hematol (2004) 0.98
Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius. Microbiology (2011) 0.97
Physical basis of the effect of hemoglobin on the 31P NMR chemical shifts of various phosphoryl compounds. Biochemistry (1988) 0.97
Ammonia permeability of erythrocyte membrane studied by 14N and 15N saturation transfer NMR spectroscopy. Am J Physiol (1995) 0.97
31P NMR spin-transfer in the phosphoglyceromutase reaction. Eur J Biochem (1984) 0.97
Effects of cholesterol on transmembrane water diffusion in human erythrocytes measured using pulsed field gradient NMR. Biophys Chem (1995) 0.96
Kinetic analysis of the human erythrocyte glyoxalase system using 1H NMR and a computer model. Eur J Biochem (1990) 0.95
Leukotriene B4 omega-oxidation by human polymorphonuclear leukocytes is inhibited by pyocyanin, a phenazine derivative produced by Pseudomonas aeruginosa. Infect Immun (1992) 0.95
Anomeric preference of fluoroglucose exchange across human red-cell membranes. 19F-n.m.r. studies. Biochem J (1992) 0.95
Solution structure of a defensin-like peptide from platypus venom. Biochem J (1999) 0.94
Elevated glutamate dehydrogenase flux in glucose-deprived hybridoma and myeloma cells: evidence from 1H/15N NMR. Biotechnol Bioeng (1998) 0.94
PCR fingerprinting: a convenient molecular tool to distinguish between Candida dubliniensis and Candida albicans. Med Mycol (2001) 0.94
Characterisation of erythrocyte shapes and sizes by NMR diffusion-diffraction of water: correlations with electron micrographs. Magn Reson Imaging (1998) 0.94
A comparison of hospital and community-acquired infective endocarditis. Am J Cardiol (1992) 0.94
Experimental colonization of broiler chicks with Campylobacter jejuni. Epidemiol Infect (1988) 0.93
Fluoride transmembrane exchange in human erythrocytes measured with 19F NMR magnetization transfer. Eur Biophys J (1990) 0.93
Evaluation of an electrochemical model of erythrocyte pH buffering using 31P nuclear magnetic resonance data. J Gen Physiol (1990) 0.93
Recommendations for the treatment of established fungal infections. Intern Med J (2008) 0.93
Dr. Walter Bayley and His Works, 1529-1592. Med Chir Trans (1907) 0.93
An audit of hip fracture services in the Mater Hospital Dublin 2001 compared with 2006. Ir J Med Sci (2009) 0.92
The assimilation of tri- and tetrapeptides by human erythrocytes. Biochim Biophys Acta (1985) 0.91
Is the antimicrobial removal device a cost-effective addition to conventional blood cultures? J Clin Pathol (1984) 0.91
Partial sequence analysis of the actin gene and its potential for studying the phylogeny of Candida species and their teleomorphs. Int J Syst Evol Microbiol (2001) 0.91
Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999-2008. J Hosp Infect (2010) 0.91
Exchange of fluorinated glucose across the red-cell membrane measured by 19F-n.m.r. magnetization transfer. Biochem J (1990) 0.90
Determination of NADH-dependent glutamate synthase (GOGAT) in Spodoptera frugiperda (Sf9) insect cells by a selective 1H/15N NMR in vitro assay. J Biotechnol (2000) 0.90
Quantitative model of NMR chemical shifts of 23Na+ induced by TmDOTP: applications in studies of Na+ transport in human erythrocytes. J Inorg Biochem (2012) 0.90
A rapid slid coagglutination test-an alternative to the fluorescent antibody test for the identification of Neisseria gonorrhoeae. J Clin Pathol (1981) 0.90
Leptospirosis presenting as a haemorrhagic fever in a traveller from Africa. Med J Aust (1997) 0.90
Recombinant interleukin 4 stimulates human immunodeficiency virus production by infected monocytes and macrophages. J Gen Virol (1992) 0.90
Biliary sepsis. Reviewing treatment options. Drugs (1986) 0.90